Patrick M. Glassman

2.0k total citations
40 papers, 1.2k citations indexed

About

Patrick M. Glassman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patrick M. Glassman has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patrick M. Glassman's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Protein purification and stability (7 papers). Patrick M. Glassman is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Nanoparticle-Based Drug Delivery (8 papers) and Protein purification and stability (7 papers). Patrick M. Glassman collaborates with scholars based in United States, China and Japan. Patrick M. Glassman's co-authors include Joseph P. Balthasar, Vladimir R. Muzykantov, Vladimir V. Shuvaev, Jacob W. Myerson, Raisa Y. Kiseleva, Elizabeth D. Hood, Laura T. Ferguson, Colin F. Greineder, Zongmin Zhao and Samir Mitragotri and has published in prestigious journals such as Advanced Materials, Circulation and Journal of Clinical Oncology.

In The Last Decade

Patrick M. Glassman

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick M. Glassman United States 20 494 235 232 231 201 40 1.2k
Colin F. Greineder United States 24 522 1.1× 178 0.8× 373 1.6× 256 1.1× 279 1.4× 66 1.5k
Sheng Wang China 23 836 1.7× 114 0.5× 157 0.7× 235 1.0× 136 0.7× 90 1.6k
Marie‐France Penet United States 24 735 1.5× 277 1.2× 188 0.8× 341 1.5× 138 0.7× 66 1.7k
Lin Li China 22 375 0.8× 375 1.6× 116 0.5× 268 1.2× 126 0.6× 151 1.6k
Mariana Varna France 21 589 1.2× 150 0.6× 187 0.8× 240 1.0× 116 0.6× 40 1.5k
Inge A. Ivens Germany 11 488 1.0× 271 1.2× 182 0.8× 124 0.5× 256 1.3× 16 1.2k
Chenying Lu China 21 530 1.1× 135 0.6× 213 0.9× 339 1.5× 86 0.4× 75 1.3k
Michael Lykke Hvam Denmark 10 968 2.0× 141 0.6× 194 0.8× 204 0.9× 110 0.5× 12 1.3k
Ian R. Corbin United States 23 685 1.4× 144 0.6× 386 1.7× 379 1.6× 112 0.6× 54 1.8k
Raffaele Allevi Italy 20 415 0.8× 76 0.3× 283 1.2× 323 1.4× 70 0.3× 35 1.1k

Countries citing papers authored by Patrick M. Glassman

Since Specialization
Citations

This map shows the geographic impact of Patrick M. Glassman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Glassman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Glassman more than expected).

Fields of papers citing papers by Patrick M. Glassman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick M. Glassman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Glassman. The network helps show where Patrick M. Glassman may publish in the future.

Co-authorship network of co-authors of Patrick M. Glassman

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick M. Glassman. A scholar is included among the top collaborators of Patrick M. Glassman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick M. Glassman. Patrick M. Glassman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yusha, et al.. (2026). The status of extracellular vesicles as drug carriers and therapeutics. Nature Reviews Bioengineering.
2.
Glassman, Patrick M., et al.. (2025). Half-life extension of therapeutics: Applications and mechanisms. Journal of Pharmacology and Experimental Therapeutics. 392(12). 103724–103724.
3.
Peshkova, Alina D., Jia Nong, Zhicheng Wang, et al.. (2025). Biomechanical and Functional Features of the Carrier Erythrocytes Prolonging Circulation Time of Biotherapeutic Targeted to Glycophorin A. Bioconjugate Chemistry. 36(2). 263–275. 3 indexed citations
4.
Nong, Jia, Jacob W. Myerson, Patrick M. Glassman, et al.. (2024). Nanocarriers' repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacy. Journal of Controlled Release. 374. 425–440. 6 indexed citations
5.
Parhiz, Hamideh, Vladimir V. Shuvaev, Qin Li, et al.. (2024). Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system. Molecular Therapy — Nucleic Acids. 35(2). 102175–102175. 11 indexed citations
6.
Glassman, Patrick M.. (2024). Development of a predictive algorithm for the efficacy of half-life extension strategies. International Journal of Pharmaceutics. 660. 124382–124382. 3 indexed citations
7.
Reyes‐Esteves, Sahily, Jia Nong, Patrick M. Glassman, et al.. (2023). Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage. Journal of Controlled Release. 356. 185–195. 23 indexed citations
8.
Myerson, Jacob W., et al.. (2023). Meta-analysis of material properties influencing nanoparticle plasma pharmacokinetics. International Journal of Pharmaceutics. 639. 122951–122951. 4 indexed citations
9.
Ferguson, Laura T., Jacob W. Myerson, Jichuan Wu, et al.. (2023). Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases. SHILAP Revista de lepidopterología. 3(3). 2200106–2200106. 19 indexed citations
10.
Ferguson, Laura T., Jacob W. Myerson, Jichuan Wu, et al.. (2023). Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases. Advanced NanoBiomed Research. 3(3). 10 indexed citations
11.
Nong, Jia, et al.. (2023). Abstract 16198: Targeting Lipid Nanoparticles to the Blood Brain Barrier to Ameliorate Acute Ischemic Stroke. Circulation. 148(Suppl_1). 1 indexed citations
12.
Nong, Jia, Patrick M. Glassman, & Vladimir R. Muzykantov. (2022). Targeting vascular inflammation through emerging methods and drug carriers. Advanced Drug Delivery Reviews. 184. 114180–114180. 29 indexed citations
13.
Glassman, Patrick M., Elizabeth D. Hood, Laura T. Ferguson, et al.. (2021). Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers. Advanced Drug Delivery Reviews. 178. 113992–113992. 72 indexed citations
14.
Glassman, Patrick M., Carlos H. Villa, Anvay Ukidve, et al.. (2020). Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics. Pharmaceutics. 12(5). 440–440. 81 indexed citations
15.
Glassman, Patrick M. & Vladimir R. Muzykantov. (2019). Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems. Journal of Pharmacology and Experimental Therapeutics. 370(3). 570–580. 129 indexed citations
16.
Glassman, Patrick M. & Joseph P. Balthasar. (2018). Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development. Drug Metabolism and Pharmacokinetics. 34(1). 3–13. 59 indexed citations
17.
Bhamidipati, Kartik, Patrick M. Glassman, Ramakrishnan Natesan, et al.. (2017). Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions. Nanomedicine Nanotechnology Biology and Medicine. 13(4). 1495–1506. 29 indexed citations
18.
Glassman, Patrick M. & Joseph P. Balthasar. (2016). Application of a catenary PBPK model to predict the disposition of “catch and release” anti-PCSK9 antibodies. International Journal of Pharmaceutics. 505(1-2). 69–78. 13 indexed citations
19.
Glassman, Patrick M., Lubna Abuqayyas, & Joseph P. Balthasar. (2015). Assessments of antibody biodistribution. The Journal of Clinical Pharmacology. 55(S3). S29–38. 31 indexed citations
20.
Glassman, Patrick M., Yang Chen, & Joseph P. Balthasar. (2015). Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys. Journal of Pharmacokinetics and Pharmacodynamics. 42(5). 527–540. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colin F. Greineder Breakdown of academic impact, for papers by Sheng Wang Breakdown of academic impact, for papers by Marie‐France Penet Breakdown of academic impact, for papers by Lin Li Breakdown of academic impact, for papers by Mariana Varna Breakdown of academic impact, for papers by Inge A. Ivens Breakdown of academic impact, for papers by Chenying Lu Breakdown of academic impact, for papers by Michael Lykke Hvam Breakdown of academic impact, for papers by Ian R. Corbin Breakdown of academic impact, for papers by Raffaele Allevi
Rankless by CCL
2026